Berman Tabacco Announces Investigation of Outset Medical Inc. (OM) for Potential Securities Law Violations
- None.
- None.
About the Investigation
On July 10, 2023, Bloomberg reported that Outset “shares decline[d] as much as
On October 12, 2023, after the market close, Outset issued a press release announcing preliminary revenue for the third quarter ended Sept. 30, 2023, and updated guidance. The Company disclosed that "[g]rowth in the quarter was dampened by a larger-than-expected impact in the field from the recent FDA warning letter, and early signs of a more cautious outlook on capital spending that we see as a headwind continuing through the fourth quarter." On October 13, 2023, shares opened at
Contact
If you have information concerning this investigation, please contact us here: Contact | Berman Tabacco.
About Berman Tabacco
Since 1982, our firm has prosecuted hundreds of securities and antitrust complex cases. The firm and its attorneys have been recognized for their work on behalf of plaintiffs, including by Chambers
The firm has offices in
This notice may constitute attorney advertising.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231013829521/en/
Berman Tabacco
Jay Eng, Esq.
One Liberty Square
Email: law@bermantabacco.com
Source: Berman Tabacco
FAQ
What is Berman Tabacco investigating?
What is Outset Medical Inc.?
Where is Berman Tabacco based?
What is the stock symbol for Outset Medical Inc.?
What kind of violations are being investigated?